Like children, pets are proving recession-resistantâ€”particularly when it comes to health-related products, such as animal supplements, nutraceutical treats and functional, natural and organic food. Read more from Nutrition Business Journal.
CHICAGOâ€”Amino acids and minerals in asparagus extract may alleviate alcohol hangover and protect liver cells against toxins, according to a study in the Journal of Food Science.
OSAKA, Japanâ€”Licorice flavonoid oil (LFO) decreased total body fat mass after eights weeks of supplementation in an Obesity Research & Clinical Practice study.
In the randomized, double blind, placebo-controlled study (2009; 3(3): 169-178), moderately overweight participants (56 males, 28 females, with a body mass index (BMI) of 24 to 30) were assigned to four groups receiving a daily dose of either 300, 600 or 900 mg of LFO, or a placebo.
AfterÂ eight weeks, all LFO groups had a significant reduction in total body fat mass. In addition, the group who received 900 mg/d experienced a significant decreases in visceral fat area, body weight, BMI and low-density lipoprotein (LDL) cholesterol. No significant adverse effects were observed.
European and American researchers showed that pancreatic cells in diabetic mice could be reprogrammed into beta cells by turning on just one gene, called Pax4.
By activating this one gene, researchers were able to reprogram cells to produce insulin, according to a study in the journal Cell. This is a major breakthrough in the understanding of possible solutions to eliminating Type1 Diabetes.
A court action has been lodged which challenges the Food and Drug Administration (FDA) qualified health claims system via five disputed selenium health claims.
The action, lodged by Jonathan W. Emord of Virginia-based law firm, Emord & Associates, states that the qualified health claims system must modify its procedures as it is preventing truthful messaging from reaching consumers, and challenges five selenium cancer health claims, reported NutraIngredients USA.
Emord said the action, which seeks â€œdeclaratory and injunctive reliefâ€ from the FDA and US Department of Health and Human Services, followed a 1999 case (Pearson versus Shalala), which validated qualified health claim messaging as a First Amendment freedom of speech right.